Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Berte, N.; Eich, M.; Koks, C. et al.

Response of monocytes and macrophages to temozolomide in mice

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 388. 2015 S. S74-S74


Sonnemann, Juergen; Grauel, Desiree; Bluemel, Lisa et al.

RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status

EUROPEAN JOURNAL OF CANCER. Bd. 51. H. 7. 2015 S. 841-851


Pencik, Jan; Schlederer, Michaela; Gruber, Wolfgang et al.

STAT3 regulated ARF expression suppresses prostate cancer metastasis

NATURE COMMUNICATIONS. Bd. 6. 2015


Pencik, Jan; Schlederer, Michaela; Gruber, Wolfgang et al.

STAT3 regulated ARF expression suppresses prostate cancer metastasis (vol 6, 7736, 2015)

NATURE COMMUNICATIONS. Bd. 6. 2015


Drube, Sebastian; Weber, Franziska; Loschinski, Romy et al.

Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells

ONCOTARGET. Bd. 6. H. 7. 2015 S. 5354-5368


Wagner, Tobias; Kiweler, Nicole; Wolff, Katharina et al.

Sumoylation of HDAC2 promotes NF-kappa B-dependent gene expression

ONCOTARGET. Bd. 6. H. 9. 2015 S. 7123-7135


Wagner, T.; Kraemer, O. H.; Heinzel, T.

Sumoylation of histone deacetylase 2 regulates tumor relevant gene expression patterns

FEBS JOURNAL. Bd. 282. 2015 S. 88-88


Drube, Sebastian; Weber, Franziska; Goepfert, Christiane et al.

TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases

ONCOTARGET. Bd. 6. H. 30. 2015 S. 28833-28850


Tomaszowski, Karl-Heinz; Aasland, Dorthe; Margison, Geoffrey P. et al.

The bacterial alkyltransferase-like (eATL) protein protects mammalian cells against methylating agent-induced toxicity

DNA REPAIR. Bd. 28. 2015 S. 14-20


Deng, Shiwei; Yan, Tiandong; Nikolova, Teodora et al.

The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells

BRITISH JOURNAL OF PHARMACOLOGY. Bd. 172. H. 9. 2015 S. 2246-2257